TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q2 2014. The put-call ratio across all filers is 10.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,281,000 | +19.0% | 452,980 | +22.4% | 0.01% | +12.5% |
| Q4 2015 | $4,439,000 | -16.1% | 369,936 | -20.0% | 0.01% | -20.0% |
| Q3 2015 | $5,292,000 | -35.1% | 462,674 | +2.5% | 0.01% | -23.1% |
| Q2 2015 | $8,155,000 | +93.4% | 451,546 | +106.2% | 0.01% | +62.5% |
| Q1 2015 | $4,216,000 | +23.1% | 219,012 | +11.8% | 0.01% | +33.3% |
| Q4 2014 | $3,425,000 | +10.9% | 195,812 | +15.9% | 0.01% | +20.0% |
| Q3 2014 | $3,088,000 | -17.1% | 169,012 | +4.5% | 0.01% | -16.7% |
| Q2 2014 | $3,724,000 | +16.2% | 161,712 | +22.3% | 0.01% | 0.0% |
| Q1 2014 | $3,205,000 | +26.0% | 132,264 | +28.3% | 0.01% | +20.0% |
| Q4 2013 | $2,544,000 | +46.3% | 103,064 | +29.0% | 0.01% | +66.7% |
| Q3 2013 | $1,739,000 | +85.4% | 79,890 | +43.5% | 0.00% | +50.0% |
| Q2 2013 | $938,000 | – | 55,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |